跳至主要内容
临床试验/NCT00217048
NCT00217048已完成1 期

Effect of Oral Yohimbine on Colonic Transit: Randomized, Placebo-Controlled Trial

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2005年6月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
Mayo Clinic
入组人数
30
试验地点
2
主要终点
Colonic transit

研究概览

简要总结

This study is being done to learn if yohimbine, a naturally occurring drug, affects the speed at which food travels through the stomach, intestines and colon, and if yohimbine affects the amount of liquid you can drink in a short period of time. Understanding how yohimbine works on the gut may help develop new treatments for patients with constipation. Yohimbine has been approved by the Food and Drug Administration (FDA) for routine clinical use, however, its use as proposed in this study is considered investigational.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy male or non-pregnant, non-breastfeeding female volunteers, -18-65 years old;
  • Able to provide written informed consent before participating in the study;
  • Able to communicate adequately with the investigator and to comply with the requirements for the entire study.

排除标准

  • 未提供

结局指标

主要结局

Colonic transit

次要结局

  • Small bowel transit time
  • Gastric emptying time
  • Maximum tolerated volume ingested during satiation testing
  • Average stools per day
  • Stool consistency

研究者

发起方
Mayo Clinic
申办方类型
Other

研究点 (2)

Loading locations...

相似试验